Search Results 981-990 of 13928 for Assay

  1. Clinical trials - Oncology (Medical)

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR). Rochester, Minn. The purpose of this ...

  2. Molecular Analysis of Human Diseases: John R. Hawse

    John R. Hawse, Ph.D., at Mayo Clinic studies hormone receptors in normal and diseased tissues, characterizes drivers of breast and ovarian cancers, ...

  3. Clinical trials - Oncology (Medical)

    ... assayed from blood of cases with CAP and controls without history of cancer. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL. Rochester, Minn., Scottsdale/Phoenix ...

  4. Myelin Regeneration - Neuroregeneration and Neurorehabilitation - Projects

    Quantitation of neurofilament light chain protein in serum and cerebrospinal fluid from patients with multiple sclerosis using the MSD R-PLEX NfL assay.

  5. Overview - Molecular Analysis of Human Diseases Laboratory - Mayo Clinic Research

    John R. Hawse, Ph.D., at Mayo Clinic studies hormone receptors in normal and diseased tissues, characterizes drivers of breast and ovarian cancers, ...

  6. Clinical trials - Oncology (Medical)

    ... assayed from blood of cases with CAP and controls without history of cancer. DALY 2.0 USA/​ MB-CART2019.1 for DLBCL. Rochester, Minn., Scottsdale/Phoenix ...

  7. Mayo Clinic, Terasaki Institute launch collaboration for transplant innovation

    That will be done by creating prognostic signatures and assays for antibody-mediated rejection of organ transplant. These initial projects are expected to ...

  8. Androgen-Deprivation Therapy And Radiation Therapy In Treating Patients With Prostate Cancer - Mayo Clinic

    ... assay (e.g., Abbott, Hybritech) within 120 days prior to registration - Study entry PSA should not be obtained during the following time frames: - Ten-day ...

  9. Efficacy And Safety Of Encaleret Compared To Standard Of Care In Participants With ADH1 - Mayo Clinic

    Participants who are in complete remission from Hepatitis C virus (HCV) as evidenced by sensitive assay ≥12 weeks after completion of HCV therapy may ...

  10. Publications - Mayo Clinic

    Using the Merlin assay for reducing sentinel lymph node biopsy complications in melanoma: a retrospective cohort study. Int J Dermatol. 2022 Jul; 61 (7):848 ...